296 related articles for article (PubMed ID: 17054308)
21. [Detection of TERC gene amplification by fluorescence in-situ hybridization in cervical intraepithelial lesions].
YUAN YL; HE CN; XU MT; XU CQ; SUN YN; ZHAO HF; CHEN C
Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):182-6. PubMed ID: 21575390
[TBL] [Abstract][Full Text] [Related]
22. Cervical intraepithelial neoplasia and aneusomy of TERC: assessment of liquid-based cytological preparations.
Ramsaroop R; Oei P; Ng D; Kumar N; Cotter PD
Diagn Cytopathol; 2009 Jun; 37(6):411-5. PubMed ID: 19191295
[TBL] [Abstract][Full Text] [Related]
23. [Clinical application of telomerase RNA component gene amplification assay in cervical lesions.].
Jiang J; Wei LH; Wu RF; Zhang G; Wulan N; Li JR; Li YB; Tu Z; Zhou YQ; Zhao Y; Chen Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Dec; 44(12):883-6. PubMed ID: 20193412
[TBL] [Abstract][Full Text] [Related]
24. Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
Li Y; Ye F; Lü WG; Zeng WJ; Wei LH; Xie X
Int J Gynecol Cancer; 2010 May; 20(4):631-7. PubMed ID: 20686384
[TBL] [Abstract][Full Text] [Related]
25. Different amplification patterns of the human telomerase RNA gene in invasive cervical carcinomas and cervical intraepithelial neoplasia grade III.
Xiang L; Yang H; Li J; Wu X; Zhou X
Diagn Cytopathol; 2012 Oct; 40(10):849-55. PubMed ID: 21381227
[TBL] [Abstract][Full Text] [Related]
26. Screening of TERC gene amplification as an additional genetic diagnostic test in detection of cervical preneoplastic lesions.
Kokalj-Vokac N; Kodric T; Erjavec-Skerget A; Zagorac A; Takac I
Cancer Genet Cytogenet; 2009 Nov; 195(1):19-22. PubMed ID: 19837263
[TBL] [Abstract][Full Text] [Related]
27. [Amplification and clinical significance of hTERC gene in the cervical exfoliated cells from natural population in Shenzhen].
Li YB; Wulan N; Liu ZH; Li J; Wang C; Zhou YQ; Wu RF
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Sep; 30(9):946-50. PubMed ID: 20193234
[TBL] [Abstract][Full Text] [Related]
28. Different amplification patterns of 3q26 and 5p15 regions in cervical intraepithelial neoplasia and cervical cancer.
Kudela E; Visnovsky J; Balharek T; Farkasova A; Zubor P; Plank L; Danko J
Ann Diagn Pathol; 2018 Aug; 35():16-20. PubMed ID: 30072014
[TBL] [Abstract][Full Text] [Related]
29. The detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study.
Yin G; Li J; Zhu T; Zhao X
World J Surg Oncol; 2012 Aug; 10():168. PubMed ID: 22909227
[TBL] [Abstract][Full Text] [Related]
30. Amplification of the 3q chromosomal region as a specific marker in cervical cancer.
Wright TC; Compagno J; Romano P; Grazioli V; Verma Y; Kershnar E; Tafas T; Kilpatrick MW
Am J Obstet Gynecol; 2015 Jul; 213(1):51.e1-51.e8. PubMed ID: 25659466
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of human telomerase RNA gene (hTERC) amplification in cervical squamous cell lesions detected by fluorescence in situ hybridization.
Jin Y; Li JP; He D; Tang LY; Zee CS; Guo SZ; Zhou J; Chen JN; Shao CK
Asian Pac J Cancer Prev; 2011; 12(5):1167-71. PubMed ID: 21875260
[TBL] [Abstract][Full Text] [Related]
32. Gain of Chromosomal Region 3q26 as a Prognostic Biomarker for High-Grade Cervical Intraepithelial Neoplasia: Literature Overview and Pilot Study.
Koeneman MM; Ovestad IT; Janssen EAM; Ummelen M; Kruitwagen RFPM; Hopman AH; Kruse AJ
Pathol Oncol Res; 2019 Apr; 25(2):549-557. PubMed ID: 30361910
[TBL] [Abstract][Full Text] [Related]
33. Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas.
Andersson S; Wallin KL; Hellström AC; Morrison LE; Hjerpe A; Auer G; Ried T; Larsson C; Heselmeyer-Haddad K
Br J Cancer; 2006 Aug; 95(3):331-8. PubMed ID: 16847471
[TBL] [Abstract][Full Text] [Related]
34. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
[TBL] [Abstract][Full Text] [Related]
35. A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques.
Ziegert C; Wentzensen N; Vinokurova S; Kisseljov F; Einenkel J; Hoeckel M; von Knebel Doeberitz M
Oncogene; 2003 Jun; 22(25):3977-84. PubMed ID: 12813471
[TBL] [Abstract][Full Text] [Related]
36. Gain of human telomerase RNA gene is associated with progression of cervical intraepithelial neoplasia grade I or II.
Lan YL; Yu L; Jia CW; Wu YM; Wang SY
Chin Med J (Engl); 2012 May; 125(9):1599-602. PubMed ID: 22800828
[TBL] [Abstract][Full Text] [Related]
37. Amplification of the human telomerase gene in liquid-based preparations is associated with cervical dysplasia and carcinoma.
Fan YB; Wu X; Fu ZM; Wu GP
Int J Gynecol Pathol; 2010 Mar; 29(2):157-64. PubMed ID: 20173501
[TBL] [Abstract][Full Text] [Related]
38. Clinical Role of the Detection of Human Telomerase RNA Component Gene Amplification by Fluorescence in situ Hybridization on Liquid-Based Cervical Samples: Comparison with Human Papillomavirus-DNA Testing and Histopathology.
Zappacosta R; Ianieri MM; Buca D; Repetti E; Ricciardulli A; Liberati M
Acta Cytol; 2015; 59(4):345-54. PubMed ID: 26343271
[TBL] [Abstract][Full Text] [Related]
39. 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases.
Alameda F; Espinet B; Corzo C; Muñoz R; Bellosillo B; Lloveras B; Pijuan L; Gimeno J; Salido M; Solé F; Carreras R; Serrano S
Hum Pathol; 2009 Oct; 40(10):1474-8. PubMed ID: 19540557
[TBL] [Abstract][Full Text] [Related]
40. Fluorescence in situ hybridization in cervical smears: detection of numerical aberrations of chromosomes 7, 3, and X and relationship to HPV infection.
Mian C; Bancher D; Kohlberger P; Kainz C; Haitel A; Czerwenka K; Stani J; Breitenecker G; Wiener H
Gynecol Oncol; 1999 Oct; 75(1):41-6. PubMed ID: 10502423
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
